发明授权
- 专利标题: Controlled absorption naproxen formulation for once-daily administration
- 专利标题(中): 受控吸收萘普生制剂,每日一次给药
-
申请号: US227566申请日: 1994-04-14
-
公开(公告)号: US5637320A公开(公告)日: 1997-06-10
- 发明人: Edward A. Bourke , Seamus Mulligan
- 申请人: Edward A. Bourke , Seamus Mulligan
- 申请人地址: IEX Athlone
- 专利权人: Elan Corporation, PLC
- 当前专利权人: Elan Corporation, PLC
- 当前专利权人地址: IEX Athlone
- 优先权: IEX149/90 19900115
- 主分类号: A61K9/00
- IPC分类号: A61K9/00 ; A61K9/14 ; A61K9/20 ; A61K9/26 ; A61K9/50 ; A61K9/54 ; A61K31/19 ; A61K31/192 ; A61K47/30 ; A61P25/04 ; A61P29/00
摘要:
A once-daily naproxen formulation for oral administration having a first portion of the naproxen as a multi-particulate pellet form, each pellet having a core of naproxen or a pharmaceutically acceptable salt thereof in association with an organic acid, the core being surrounded by a multi-layer membrane and optionally a second portion of naproxen formulated to release the drug promptly following oral administration.
公开/授权文献
- US4945750A Press forging of molybdenum or molybdenum alloy parts 公开/授权日:1990-08-07
信息查询